Behavioral Health

Supervised injection or safe consumption sites are places people could go to use illegal drugs while being monitored by medical experts.

Lawmakers are considering establishing a yearly cost-of-living rate adjustment for adult disability and mental health services.

The act of "reaching for a cup of coffee" has scientists at Washington University School of Medicine in St. Louis finding previously overlooked active areas of the brain.

The U.S. Drug Enforcement Administration issued an alert Monday warning of a "sharp increase in the trafficking of fentanyl mixed with xylazine."

The first year of settlement funds from national opioid lawsuits have reached Camden County, where officials will prioritize treatment and naloxone access.

After some setbacks, the Pallet Village in Georgetown finally opens, housing nearly 50 people experiencing homelessness and other challenges.

The FDA is considering a nonprescription, over-the-counter version of Narcan’s nasal spray for opioid overdoses. But experts worry about affordability.

A documentary play at Louis Bluver Theatre is abruptly interrupted every 5 minutes and 39 seconds by another overdose death. That rate is quickening.

Starting this year, the returning local chapter will provide support and education for people in the county dealing with mental illnesses as well as their families.

Fentanyl test strips, which can detect the deadly synthetic opioid in drugs, were previously considered as illegal drug paraphernalia under state law.

Chester County hopes to deploy the mobile mental health crisis teams starting July 2023 as part of a new three-pillar approach to mental and behavioral health services.

Researchers find that pandemic grief is on par with violent-death grief — and what makes both so traumatic

The Biden administration will use data from EMS first responders to track overdoses.

Philadelphia’s Safehouse says the U.S. Department of Justice is out of time to make a decision on supervised injection sites.

A new study, led by a Rutgers researcher, found that buprenorphine, rather than methadone, may be safer for infants born to mothers getting treatment for opioid use disorder.